Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 15.07.2025
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Capital increase at LIMES Schlosskliniken AG to service stock options
Köln, July, 15, 2025 – The Management Board of LIMES Schlosskliniken AG (ISIN: DE000A0JDBC7) today resolved, with the approval of the Supervisory Board, to increase the company's share capital by 4,760 shares from authorized capital in ac [ … ]
Tue, 15.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology.
Sevenum, the Netherlands, 15 July 2025. Today Redcare Pharmacy was notified by its technology partner eHealth Experts that an extension until 31 January 2027 for its CardLink product license has been recei [ … ]
Tue, 15.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy’s CardLink solution extended by gematik.
Sevenum, 15 July, 2025. Through its technology partner, eHealth Experts, Redcare Pharmacy N.V. today received confirmation that its CardLink solution license for the redemption of e-prescriptions in Germany has been extended by the German National Digital Health Agency (gematik) until 31 Ja [ … ]
Tue, 15.07.2025
CPI PROPERTY GROUP
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED [ … ]
Tue, 15.07.2025
Samara Asset Group PLC
Company Name:
Samara Asset Group PLC
ISIN:
MT0001770107
Reason for the research:
Research Comment
Recommendation:
BUY
Target price:
3.93 EUR
Target price on sight of:
31.12.2026
Last rating change:
Analyst:
Matthias Greiffenberger, Cosmin Filker
Bitcoin’s price correction through the quarter weighed directly on Samara&r [ … ]
Tue, 15.07.2025
Gerresheimer AG
Gerresheimer Achieves A- Score in CDP Rating
“Leadership” status in climate action
Rating recognizes transparent management of CO2 emissions
Ambitious reduction target: 50% CO2 emissions cut by 2030
Düsseldorf, July 15, 2025. Gerresheimer, an innovative system and solutions provider and global partner to the pharmaceutical, biotech, and cosmetic [ … ]
Tue, 15.07.2025
Mallia Innovations
Mallia Innovations appoints five leading international experts in hair science to its Scientific Advisory Board
Erlangen, Germany, July 15, 2025 – Mallia Innovations GmbH, driving the development and commercialization of biopharmaceutical therapies targeting hair loss and wound healing as well as cosmetic applications for hair growth, today announ [ … ]
Tue, 15.07.2025
thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera Continues Stable Business Development in the Third Quarter and Specifies Outlook for 2024/2025
Stable operational business development in the third quarter and first nine months of 2024/2025 for thyssenkrupp nucera
Based on preliminary, unaudited figures, the electrolyzer specialist's order intake in the third quarter was EUR [ … ]
Tue, 15.07.2025
thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 business development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment
thyssenkrupp nucera AG & Co. KGaA ("thyssenkrupp nucera"), based on the preliminary business development of the first nine months of 2024/25, specif [ … ]
Tue, 15.07.2025
AATec Medical GmbH
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin
Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad mu [ … ]
